Case number 1:20-cv-00273
Astellas US LLC et al v. International Medication Systems, Limited > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jan 27, 2022 | N/A | Terminated Case (0) Docket Text: CASE CLOSED per the "So Ordered" of the Stipulation of Dismissal filed in Lead Case No. 18-1675-CFC. (nmf) |
| Jan 27, 2022 | 16 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal as to International Medication Systems, Ltd by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 30, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re (15 in 1:20-cv-00273-CFC) Stipulation To Consolidate Action filed by Gilead Sciences, Inc., Astellas Pharma US, Inc., Astellas US LLC. C.A. No. 20-00273-CFC and C.A. No. 18-1675-CFC are consolidated for all purposes; All future filings shall be made in C.A. No. 18-1675-CFC. ( See stipulation for further details and deadlines). Ordered by Judge Colm F. Connolly on 3/30/2020. Associated Cases: 1:20-cv-00273-CFC, 1:18-cv-01675-CFC-CJB(fms) |
| Mar 30, 2020 | N/A | Create Case Association (0) Docket Text: Case associated with lead case: Create association to 1:18-cv-01675-CFC-CJB. ALL FUTURE FILINGS SHALL BE MADE IN C.A. No. 18-1675-CFC. (fms) |
| Mar 30, 2020 | 15 | Stipulation (4) Docket Text: STIPULATION and Proposed Order to Consolidate Action by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc.. (Oakes, Robert) |
| Mar 18, 2020 | 14 | Order (1) Docket Text: ORDER, this case having been recently joined and ready for scheduling pursuant to Fed. R. Civ. P. 16 and as this case is listed as related to earlier filed cases that are currently proceeding on an agreed upon schedule entered by the Court; IT IS ORDERED that, on or before April 20, 2020, counsel for the parties shall confer regarding coordination of the cases and submit a proposed scheduling order to the Court or otherwise advise the Court that a separate scheduling conference is needed. ORDER, Setting Deadlines: Notice of Compliance deadline set for 4/20/2020. Signed by Judge Colm F. Connolly on 3/18/2020. (nmf) |
| Mar 16, 2020 | 12 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of CONFIDENTIAL Astellas US LLC, Astellas Pharma US, Inc., and Gilead Sciences, Inc.'s Disclosures Pursuant to Paragraph 3 and 4a of the Delaware Default Standard for Discovery; and Plaintiffs' Fed. R. Civ. P. 26(a)(1) Initial Disclosures filed by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 16, 2020 | 13 | Notice of Service (3) Docket Text: NOTICE OF SERVICE of 1. International Medication Systems, Ltd.s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a) 2. International Medication Systems, Ltd.s Initial Disclosures Pursuant to Paragraph 3 of the District of Delaware Default Standard for Discovery filed by International Medication Systems, Limited.(Hoeschen, Nathan) |
| Mar 13, 2020 | 11 | Answer to Counterclaim (9) Docket Text: ANSWER to [8] Answer to Complaint, Counterclaim by Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc..(Oakes, Robert) |
| Mar 11, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [10] MOTION for Pro Hac Vice Appearance of Attorney John T. Bennett, Sarah J. Fischer and Natasha E. Daughtrey filed by International Medication Systems, Limited. Signed by Judge Colm F. Connolly on 3/11/2020. (fms) |
| Mar 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Sarah J Fischer,Natasha E. Daughtrey,John T. Bennett for International Medication Systems, Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lak) |
| Mar 11, 2020 | 10 | Motion for Leave to Appear Pro Hac Vice (5) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney John T. Bennett, Sarah J. Fischer and Natasha E. Daughtrey - filed by International Medication Systems, Limited. (Keller, Karen) |
| Mar 4, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. (rjb) |
| Mar 4, 2020 | 8 | Answer to Complaint (25) Docket Text: ANSWER to [1] Complaint, Defenses, And, COUNTERCLAIM against Astellas Pharma US, Inc., Astellas US LLC, Gilead Sciences, Inc. by International Medication Systems, Limited.(Keller, Karen) |
| Mar 4, 2020 | 9 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amphastar Pharmaceuticals, Inc. for International Medication Systems, Limited filed by International Medication Systems, Limited. (Keller, Karen) |
| Feb 25, 2020 | N/A | Summons Issued (0) Docket Text: Summons Issued with Magistrate Consent Notice attached as to International Medication Systems, Limited on 2/25/2020. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (sam) |
| Feb 25, 2020 | 1 | Main Document (13) Docket Text: COMPLAINT FOR PATENT INFRINGEMENT filed against International Medication Systems, Limited - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2862660.) - filed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. (Attachments: # (1) Exhibit A, # (2) Exhibit B, # (3) Exhibit C, # (4) Exhibit D, # (5) Civil Cover Sheet)(sam) |
| Feb 25, 2020 | 1 | Exhibit A (22) |
| Feb 25, 2020 | 1 | Exhibit B (22) |
| Feb 25, 2020 | 1 | Exhibit C (20) |
| Feb 25, 2020 | 1 | Exhibit D (18) |
| Feb 25, 2020 | 1 | Civil Cover Sheet (1) |
| Feb 25, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (sam) |
| Feb 25, 2020 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 8, 2020. Date of Expiration of Patent: February 2, 2027.Thirty Month Stay Deadline: 08/08/2022. (sam) (Main Document 3 replaced on 2/26/2020) (mal). Modified on 2/26/2020 (mal). |
| Feb 25, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 8,106,183 ;US RE 47,301 E ;US 8,524,883. (sam) |
| Feb 25, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Gilead Sciences, Inc. (sam) |
| Feb 25, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Astellas US Holding, Inc. for Astellas Pharma US, Inc., Astellas US LLC filed by Astellas Pharma US, Inc., Astellas US LLC. (sam) |
| Feb 25, 2020 | 7 | Summons Returned Executed (3) Docket Text: SUMMONS Returned Executed by Astellas US LLC, Astellas Pharma US, Inc., Gilead Sciences, Inc.. International Medication Systems, Limited served on 2/25/2020, answer due 3/17/2020. (Oakes, Robert) |
| Feb 25, 2020 | 1 | Complaint* (1) |
